A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus -host disease prophylaxis in haploidentical transplant

(2016) Annalisa Ruggeri et al.   HAEMATOLOGICA

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus -host disease prophylaxis in haploidentical transplant

(2016) Annalisa Ruggeri et al.   HAEMATOLOGICA

Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation

(2016) Stephanie J. Lee et al.   JAMA Oncology

Influence of Stem Cell Source on Outcomes of Allogeneic Reduced-Intensity Conditioning Therapy Transplants Using Haploidentical Related Donors

(2015) Kenneth Bradstock et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells

(2015) Nicoletta Cieri et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research

(2015) Michael R. Verneris et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

(2015) S. O. Ciurea et al.   BLOOD

Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission

(2015) A Ruggeri et al.   BONE MARROW TRANSPLANTATION

Bone Marrow or Peripheral Blood for Reduced-Intensity Conditioning Unrelated Donor Transplantation

(2015) Mary Eapen et al.   JOURNAL OF CLINICAL ONCOLOGY

Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling Grafts

(2014) Anna Maria Raiola et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen–Matched Unrelated and Related Donors

(2014) Antonio Di Stasi et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide

(2014) Luca Castagna et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

(2014) Y. Luo et al.   BLOOD

A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia

(2014) S Piemontese et al.   LEUKEMIA

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors

(2014) J Peccatori et al.   LEUKEMIA

T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation

(2013) Asad Bashey et al.   JOURNAL OF CLINICAL ONCOLOGY

A tutorial on propensity score estimation for multiple treatments using generalized boosted models

(2013) Daniel F. McCaffrey et al.   STATISTICS IN MEDICINE

Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning

(2012) Anna Maria Raiola et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies

(2012) P. Di Bartolomeo et al.   BLOOD

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION